You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CAFERGOT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Cafergot, and what generic alternatives are available?

Cafergot is a drug marketed by Novartis and Sandoz and is included in three NDAs.

The generic ingredient in CAFERGOT is caffeine; ergotamine tartrate. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the caffeine; ergotamine tartrate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CAFERGOT?
  • What are the global sales for CAFERGOT?
  • What is Average Wholesale Price for CAFERGOT?
Summary for CAFERGOT
US Patents:0
Applicants:2
NDAs:3
Clinical Trials: 3
DailyMed Link:CAFERGOT at DailyMed
Drug patent expirations by year for CAFERGOT
Recent Clinical Trials for CAFERGOT

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rajavithi HospitalPhase 3
Stanford UniversityPhase 2
Vanderbilt UniversityPhase 1

See all CAFERGOT clinical trials

US Patents and Regulatory Information for CAFERGOT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis CAFERGOT caffeine; ergotamine tartrate SUPPOSITORY;RECTAL 009000-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novartis CAFERGOT caffeine; ergotamine tartrate TABLET;ORAL 006620-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz CAFERGOT caffeine; ergotamine tartrate TABLET;ORAL 084294-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.